GlaxoSmithKline PLC — Director's Dealing 2016

Jul 20, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6647E

GlaxoSmithKline PLC

19 July 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr P J T Vallance

b)

Position/status

President, Pharmaceuticals R&D

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882 

b)

Nature of the transaction

Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Performance Share Plan.

c)

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.285	2,373.465
£16.285	2,433.599
£16.285	3,002.493

d)

Aggregated information

Aggregated volume Price

7,809.558

£16.285

e)

Date of the transaction

2016-07-14

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHVKLFFQDFFBBQ

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'rnijNzVYLP36zJPF5ZF2t-ghlxA_wDsDq8Uxu287E22dzd3tJ9lw5wRHrby_jrilt6JcuTEQ7Ul5gmKradyz_gILPI9jpr4IijoKnEBNvO41:IuApCenCdfHPcFW33ChWazUlA_jhyMnWN-MKRLLZuTz3PA9uVYMcYkJaomZJbTENLoiDqpXsmhP0Ghvi3AuINHQvU3RM35bzvR4ORIvQQ2c1'}});//]]>